-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Arcutis Biotherapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q1 2019 to Q1 2024.
- Arcutis Biotherapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $170K, a 2.86% decline year-over-year.
- Arcutis Biotherapeutics, Inc. Depreciation for the twelve months ending March 31, 2024 was $766K, a 18.4% increase year-over-year.
- Arcutis Biotherapeutics, Inc. annual Depreciation for 2023 was $771K, a 24% increase from 2022.
- Arcutis Biotherapeutics, Inc. annual Depreciation for 2022 was $622K, a 37% increase from 2021.
- Arcutis Biotherapeutics, Inc. annual Depreciation for 2021 was $454K, a 272% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)